Moody Lynn & Lieberson LLC Trims Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Moody Lynn & Lieberson LLC trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 22.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,405 shares of the financial services provider’s stock after selling 1,600 shares during the period. Moody Lynn & Lieberson LLC’s holdings in iShares Biotechnology ETF were worth $715,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of IBB. PVG Asset Management Corp purchased a new stake in shares of iShares Biotechnology ETF in the second quarter valued at $415,000. Huntington National Bank raised its stake in iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after purchasing an additional 160 shares during the last quarter. National Bank of Canada FI lifted its holdings in iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after purchasing an additional 229 shares in the last quarter. First Financial Bank Trust Division acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth about $204,000. Finally, Thrive Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $445,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $137.30 on Friday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The company’s 50 day simple moving average is $136.04 and its 200 day simple moving average is $141.80.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.